HCW Biologics (HCWB) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
HCW Biologics is the larger company by market cap ($3.6 million vs $3.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HCWB | SXTP |
|---|---|---|
| Share price | $1.60 | $0.9654 |
| Market cap | $3.58M | $3.40M |
| 1-day change | +4.58% | -0.73% |
| EPS (TTM) | $-21.01 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.30 | $8.62 |
| 52-week low | $1.50 | $0.84 |
| Distance from 52-week high | -94.14% | -88.80% |
| Analyst consensus | buy | none |
| Avg. price target upside | +2900.00% | +283.26% |
| Average volume | 381.72K | 132.31K |
| Shares outstanding | 2.24M | 3.52M |
| Employees | 35 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About HCW Biologics
HCWB stock →HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 35 employees
About 60 Degrees Pharmaceuticals
SXTP stock →60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
HCWB vs SXTP FAQ
Which is bigger, HCW Biologics or 60 Degrees Pharmaceuticals?
HCW Biologics (HCWB) is larger, with a market capitalization of $3.58M compared with $3.40M for 60 Degrees Pharmaceuticals (SXTP).
Are HCW Biologics and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.